Patient Health and Real Medication Access Cost Savings Act of 2009

Healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding; proposed revisions to the blood glucose local coverage determination H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medicare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act of 2009; all sections S. 1796 - America's Healthy Future Act of 2009; sections 1001 - 2221 H.R. 3790 - To amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Rate Commission, Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS)

Healthcare reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections H.R. 4199 - Patient Health and Reinvestment Act of 2009; all sections H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Rate Commission, Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS)

Issues related to comprehensive health care reform: Health Information Technology; ARRA Privacy and Security Rules; Generic Biologics; Comparative Effectiveness; Importation of Prescription Drugs; Competitive Bidding; Chronic Care Management; Healthcare Reform; and Healthcare Implementation H.R. 1 - American Recovery and Reinvestment Act of 2009; Title VIII Department of Labor, Health and Human Services, and Education, and related agencies; Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections H.R. 1321 and S. 391 - Healthy Americans Act; all sections H.R. 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections H.R. 1548- Pathway for Biosimilars Act; all sections H.R. 3200 - America's Affordable Health Choices Act; all sections H.R. 3596 - Health Insurance Industry Antitrust Enforcement Act of 2009; all sections H.R. 3962 - Affordable Healthcare for America Act; all sections Public Law 111-148 - Patient Protection and Affordable Care Act; all sections (formerly H.R. 3590) H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections Public Law 111-152 - Health Care and Education Reconciliation Act of 2010; all sections (formerly H.R. 4872 and S. Con. Res. 13) H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5235 - The Medicare Access to Diabetes Supplies Act; all sections H.R. 3790 - To Amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections Public Law 104-191 - Health Insurance Portability and Accountability Act (HIPAA); Title II H.R. 5440 - Genomics and Personalized Medicine Act of 2010; all sections

Issues related to anti-PBM legislation, disclosure of proprietary pricing and contracting information. Other issues included health care delivery system reforms, cost containment, restrictions on PBM cost saving tools like mail order, and generics, restrictions on PBM audit practices and new rules around IRS Form 1099. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009 HR 5234 PBM Audit Reform and Transparency Act of 2010 HR 4489 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act

Client expense: $2,189,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act

Client expense: $36,675 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act

Client expense: $36,675 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4199, The Patient Health nd Real Medication Access Cost Savings Act HR 5234, PBM Audit Reform and Transparency Act

Client expense: $36,675 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4199, Patient Health and Real Medication Access Cost Savings Act of 2009

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Items related to reverse settlement payments between manufacturers--HR 1706, S 369; Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489; Regulatory design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements; Policies related to restricting PBMS' ability to manage prescription drug benefits-- HR 4199; PBM Audit Reform & Transparency Act--HR 5234.

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $525,828 · Firm income: Not reported

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Issues related to implementation of the Patient Protection and Affordable Care Act including prescription drug coverage, formulary requirements, generic drug co-payments, direct negotiation, Medicaid rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $525,828 · Firm income: Not reported

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $525,828 · Firm income: Not reported

Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacists; eliminate spread pricing; return rebates to health plans; and create a fund to pay for medicines for low-income individuals.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacists; eliminate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation concerning privacy regarding inadvertent disclosure of protected health information; HR 5777 (Rush Privacy bill); S. 3742-Data Security and Breach Notification Act of 2010. Legislation concerning pharmacy benefit management issues, drug safety and tracking drug suppliers; S.3397, HR 1359, HR 5710. (et al., HR 4199, HR 5234, HR 4489, HR 4213).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare Demonstration Projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medciare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act; all setions S. 1793 - America's Health Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $960,000 · Firm income: Not reported

healthcare reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program Public Law 111-148 - Patient Protection and Affordable Care Act (formerly H.R. 3590); all sections H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections H.R. 4199 - Patient Health and Reinvestment Act of 2009 H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections

Client expense: $960,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Regulatory Commission, SENATE

Issues related to comprehensive health care reform: Health Information Technology; ARRA Privacy and Security Rules; Generic Biologics; Comparative Effectiveness; Chronic Care Management; Healthcare Reform; and Healthcare Implementation H.R. 1- American Recovery and Reinvestment Act of 2009; Title VIII Department of Labor, Health and Human Services, and Education, and related agencies; Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections H.R. 1321 and S. 391 - Healthy Americans Act; all sections H.R. 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections H.R. 1548 - Pathway for Biosimilars Act; all sections H.R. 3200 - America's Affordable Health Choices Act; all sections H.R. 3596 - Health Insurance Industry Antitrust Enforcement Act of 2009; all sections H.R. 3962 - Affordable Healthcare for America Act; all sections Public Law 111-148 - Patient Protection and Affordable Care Act; all sections (formerly H.R. 3590) H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections Public Law 111-152 - Health Care and Education Reconciliation Act of 2010; all sections (formerly H.R. 4872 and S. Con. Res. 13) H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5235 - The Medicare Access to Diabetes Supplies Act; all sections H.R. 3790 - To Amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections Public Law 104-191 - Health Insurance Portability and Accountability Act (HIPAA); Title II H.R. 5440 - Genomics and Personalized Medicine Act of 2010; all sections

Client expense: $960,000 · Firm income: Not reported

H.R. 4199, Patient Health and Real Medication Access Cost Savings Act of 2009

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of network pharmacies. Issues relating to the inadvertent disclosure of protected health information. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009 HR 5234 PBM Audit Reform and Transparency Act of 2010 HR 4489 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act HR 5777 - To foster transparency about the commercial use of personal information, provide consumers with meaningful choice about the collection, use, and disclosure of such information, and for other purposes. (Rush Privacy bill) S 3742 - Data Security and Breach Notification Act of 2010

Client expense: $2,550,000 · Firm income: Not reported

Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act

Client expense: $430,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Support legislation (HR4199) to define pharmacists as health care professionals under Medicare; increase dispensing fees for pharmacies; elimiate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund to pay for prescription medicines for low-income indidviduals.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaide rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $644,766 · Firm income: Not reported

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $644,766 · Firm income: Not reported

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $644,766 · Firm income: Not reported

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of suspect network pharmacies. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009; HR 5234 PBM Audit Reform and Transparency Act of 2010. Issues relating to a proposed anti-trust exemption for certain pharmacies, healthcare competition and the CVS Caremark business model. HR 1204 - Community Pharmacy Fairness Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

health care reform; antitrust exemptions for independent pharmacists; PBM auditing rules; mail order pharmacy; federal employee health benefits program Public Law 111-148 - Patient Protection and Affordale Care Act; all sections (formerly H.R. 3590) H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5234 - PBM Audit Reform and Transparency Act of 2010; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections H.R. 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections

Client expense: $600,000 · Firm income: Not reported

health care ceform, health care regulations, Medicare Part D, proposed antitrust exemptions for certain pharmacists, IVIG payments, Medicare Demonstration Projects for durable medical equipment, importation of prescription drugs, home infusion, disclosure of PBM information, changes to drug benefits offered under the FEHBP and increasing healthcare value. H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Health Care for America Act; all sections S 1793 - America's Healthy Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $600,000 · Firm income: Not reported

Issues related to comprehensive health care reform: Health Information Technology, ARRA Privacy and Security Rules, generic biologics, comparative effectiveness, chronic care management, health care reform, and health care implementation H.R. 1 - American Recovery and Reinvestment Act of 2009; title VIII Departments of Labor, Health and Human Services, and Education, and related agencies, Healthcare Research adn Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections H.R. 1321 and S. 391 - Healthy Americans Act; all sections H.R. 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections H.R. 1548 - Pathway for Biosimilars Act; all sections H.R. 3200 - American's Affordable Health Choices Act; all sections H.R. 3596 - Health Insurance Industry Antitrust Enforcement Act of 2009; all sections H.R. 3962 - Affordable Healthcare for America Act; all sections Public Law 111-148 - Patient Protection adn Affordable Care Act; all sections (formerly H.R. 3590) H.R. 4199 - Patient Health adn Real Medication Access Cost Savings Act; all sections Public Law 111-152 - Health Care and Education Reconciliation Act of 2010; all sections (formerly H.R. 4872 and S. Con. Res. 13) H.R. 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections H.R. 5235 - The Medicare Access to Diabetes Supplies Act; all sections H.R 3790 - To Amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections Public Law 104-191 - Health Insurance Portability and Accountability Act (HIPAA); Title II H.R. 5440 - Genomics and Personalized Medicine Act of 2010; all sections

Client expense: $600,000 · Firm income: Not reported

H.R.4213, The American Jobs and Closing Tax Loopholes Act of 2010 H.R.4199, the Patient Health and Real Medication Access Cost Savings Act of 2009 H.R.5234, the PBM Audit Reform and Transparency Act of 2010

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaide rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $551,889 · Firm income: Not reported

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $551,889 · Firm income: Not reported

H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act

Client expense: $551,889 · Firm income: Not reported

Establishing a regulatory approval pathway for biogeneric drugs - H.R. 1427/S726 - Promoting Innovation and Access to Life Saving Medicine Act and H.R. 1548 - Pathway for Biosimilars Act Items related to the application of drug benenfits to public plans and health exchange, including PBM disclosure in H.R. 3000, S169 - America's Health Future Act, H.R. 3962, H.R. 3950 - Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Client expense: $551,889 · Firm income: Not reported

Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care and PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaide rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, H.R. 3200, S1679 America's Health Future Act, H.R. 3950 Patient Protection and Affordable Care Act. H.R. 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Client expense: $551,889 · Firm income: Not reported

Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act

Client expense: $410,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to corporate business model, specifically anti-PBM legislation and disclosure of proprietary pricing and contracting information and improvements to health care delivery and cost containment. Restrictions on PBM cost saving tools like mail order, generics and discount programs. Changes to PBM audit of suspect network pharmacies. HR 4199 Patient Health and Real Medication Access Cost Savings Act of 2009 HR 5234 PBM Audit Reform and Transparency Act of 2010

Client expense: $2,250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescrption drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health plans; and create a fund to pay for prescription medicines for low-income individuals.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

HR 5234 HR 1204 HR 4199

Client expense: Not reported · Firm income: Not reported

Health Care Reform, Medicare Part D, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment, Importation of Prescription Drugs, Home Infusion HR 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections HR 1204 - Community Pharmacy Fairness Act of 2009; all sections HR 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program; all sections HR 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections HR 3962 - Affordable Health Care for America Act; all sections HR 3590 - Patient Protection and Affordable Care Act; all sections S1793 - America's Healthy Future Act of 2009; all sections HR 4752 - Medicare Prescription Drug Price Negotiation Act of 2010 HR 4872 - Healthcare and Education Reconciliation Act of 2010; all sections

Client expense: $960,000 · Firm income: Not reported